Raising the Bar for Therapeutic Trials in Advanced Prostate Cancer

被引：2

作者：

Alumkal, Joshi J. ^{[1
]}

Beer, Tomasz M. ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

来源：

关键词：

DOCETAXEL PLUS PREDNISONE; PHASE-III TRIAL; DOUBLE-BLIND; CLINICAL-TRIALS; PLACEBO; MEN; CABOZANTINIB; MITOXANTRONE; COMBINATION;

D O I：

10.1200/JCO.2016.68.0439

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：2958 / +

页数：5

共 50 条

[41] Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications
Ryan, Matthew J.
Bose, Rohit
FRONTIERS IN ONCOLOGY, 2019, 9
[42] Cholesterol transport protein in therapeutic targeting of advanced prostate cancer
Pflug, B. R.
Fafalios, A.
Akhavan, A.
Parwani, A.
BJU INTERNATIONAL, 2007, 100 : 35 - 35
[43] Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer
Barquilha, Caroline N.
Santos, Nilton J.
Moncao, Caio C. D.
Barbosa, Isabela C.
Lima, Flavio O.
Justulin, Luis A.
Pertega-Gomes, Nelma
Felisbino, Sergio L.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
[44] Therapeutic options in locally defined or advanced prostate cancer - Discussion
Zerbib, M
Altwein, JE
Zip, C
EUROPEAN UROLOGY, 1999, 35 : 16 - 16
[45] Raising the BAR
Mahbubani, Krishnaa
Edwards, Alexander
Slater, Nigel
TCE, 2010, (824): : 28 - 31
[46] Raising the bar
Masonry Construction the world of Masonry, 2002, 15 (12): : 24 - 26
[47] Raising the bar
Spillane, Chris
TCE, 2006, (785): : 68 - 68
[48] Raising the bar
Piven, H
FORTUNE, 2000, 141 (04) : 116 - 117
[49] Raising the Bar
Turner, Fred
ASHRAE JOURNAL, 2010, 52 (08)
[50] Raising the bar
Frantz, S
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (04) : 254 - 254